You can help!

For decades, mental health treatment options have excluded the very promising segment of psychedelic-assisted therapies. Just as psychiatrists, psychologists, and other researchers were making incredible headway on their studies of compounds like MDMA, psilocybin, and Ayahuasca (among others) in the 1990’s, the U.S. government criminalized these substances, blocking research across the globe. Now, in 2024, that is about to change.

Efficacy rates for treating PTSD with MDMA-assisted therapy exceed 87% in clinical trials! In August of 2024, we anticipate the legalization of MDMA for the treatment of PTSD in the United States. A sea change is upon us. The exploration and availability of other psychedelic-assisted treatments should follow. The extraordinary promise of these therapeutic modalities cannot be overlooked, as the efficacy and impact of these treatments are setting a new bar for effective, safe, and enduring mental health treatments. Your support can accelerate the spread of traumatic recovery.

I was there when Blake Mycoskie, founder of the Toms shoe brand, pledged $100 million toward psychedelic research and access. “I don’t see a chance in my lifetime to be part of something else that could end so much human suffering,” Mycoskie said on that stage at the MAPS Psychedelic Science conference in Denver (June 2023).

Even when we are able to connect women across the globe to legalized psychedelic therapies, there is still much work to be done in advance of that legalization. Education destigmatizes PTSD/Complex PTSD, and helps everyone identify the systemic barriers to effective therapies for women. When women are correctly diagnosed, they can be restored. We must help marginalized populations share access to these emerging therapies. You can help us shape the global impact of trauma while ensuring that women are not left behind.